Publications by authors named "David Swirsky"

Claim this Profile
C
Case report and magnetic resonance images of sclerosing angiomatoid nodular transformation (SANT) of the spleen.
Maruthesh Gowda Chikkappa, Charles Morrison, Andrew Lowe, Ralph Antrim, David Michael Swirsky

BMJ Case Rep· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paravertebral extramedullary haemopoiesis occurring in a case of congenital dyserythropoietic anaemia type II.
Agha Imran, Rod Mawhinney, David Swirsky, Claire Hall

Br J Haematol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia.
Rosemary E Gale, Robert Hills, Arnold R Pizzey, Panagiotis D Kottaridis, David Swirsky

Blood· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic variation in XPD predicts treatment outcome and risk of acute myeloid leukemia following chemotherapy.
James M Allan, Alexandra G Smith, Keith Wheatley, Robert K Hills, Lois B Travis, David M Swirsky

Blood· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and progression of a Philadelphia-chromosome-negative acute myelocytic leukemia clone in a patient with Philadelphia-chromosome-positive chronic myelocytic leukemia.
Matthew J Cullen, Stephen J Richards, Helen Dickinson, Chris Carter, David M Swirsky

Cancer Genet Cytogenet· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid diagnosis of acute promyelocytic leukemia (PML): applicability of flow cytometry and PML protein immunofluorescence.
Matthew J Cullen, Stephen J Richards, Sheila J M O'Connor, Helen Dickinson, Carol Sharpe, David M Swirsky

Cancer Genet Cytogenet· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poor metabolizer status at the cytochrome P450 2C9 and 2D6 loci does not modulate susceptibility to therapy-related acute myeloid leukaemia.
Philippa L Roddam, James M Allan, Sara Rollinson, Alexandra G Smith, Eleanor V Willett, David Swirsky

Br J Haematol· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis